MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 31.2752

Change

-0.08 (-0.26)%

Market Cap

N/A

Volume

275.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

-0.35 (-0.18%)

USD 31.98B
ACWI iShares MSCI ACWI ETF

-0.47 (-0.40%)

USD 18.45B
IBIT iShares Bitcoin Trust

-0.21 (-0.58%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

+0.02 (+0.10%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.01 (-0.02%)

USD 16.09B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.04 (+0.08%)

USD 3.07B
IBTF iShares iBonds Dec 2025 Term T..

+0.02 (+0.06%)

USD 2.07B
IBTE iShares iBonds Dec 2024 Term T..

+0.01 (+0.04%)

USD 2.06B
PABU iShares Paris-Aligned Climate ..

-0.22 (-0.35%)

USD 2.05B
NVDL GraniteShares 1.5x Long NVDA D..

-1.81 (-3.27%)

USD 2.05B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.98% 73% C 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.98% 70% C- 68% D+
Trailing 12 Months  
Capital Gain 6.31% 49% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.31% 41% F 50% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.28% 51% F 44% F
Dividend Return 0.28% 45% F 40% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1.09% 98% N/A 100% F
Risk Adjusted Return 25.40% 53% F 59% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector